Displaying results for your search.
Publication - Abstract
Mar 16, 2021
ACS Nano
Publication - Abstract
Mar 15, 2021
Acta Biomaterilia
Publication - Abstract
Feb 16, 2021
Communications Biology
Publication - Abstract
Sep 26, 2020
cancers
Publication - Abstract
Jun 20, 2020
Advanced Drug Delivery Reviews
Publication - Abstract
Jun 07, 2020
Pharmaceutics
Publication - Abstract
Mar 10, 2020
ACS Chemical Biology
Publication - Summary
Jan 14, 2019
Cancer Immunology, Immunotherapy
Publication - Abstract
Oct 29, 2018
Nature Communications
Publication - Abstract
Jun 13, 2018
Bioconjugate Chemistry
Publication - Abstract
Apr 16, 2018
Acta Biomaterialia
Macrophage hyperfunction or dysfunction is tightly associated with various diseases, such as osteoporosis, inflammatory disorder, and cancers. However, nearly all conventional drug delivery system (DDS) nanocarriers utilize endocytosis for ent...
Publication - Abstract
Jan 29, 2018
Nature Nanotechnology
Previous studies have identified relevant genes and signalling pathways that are hampered in human disorders as potential candidates for therapeutics. Developing nucleic acid-based tools to manipulate gene expression, such as short interfering RNAs...
Publication - Abstract
Apr 03, 2016
Nucleic Acids
The androgen receptor plays a critical role in the progression of prostate cancer. Here, we describe targeting the prostate-specific membrane antigen using a lipid nanoparticle (LNP) formulation containing small interfering RNA (siRNA) designed to ...
Publication - Abstract
Oct 14, 2015
Chemical Reviews
Described first in the 1960s by Bangham1 and understood as a potential drug delivery system in the early 1970s,2−4 the liposome has since become integral to research and clinical applications in the field of nanomedicine.
Publication - Abstract
Jun 10, 2015
ACS Nano
Modulating T cell function by down-regulating specific genes using RNA interference (RNAi) holds tremendous potential in advancing targeted therapies in many immune-related disorders including cancer, inflammation, autoimmunity,...
Publication - Summary
Feb 24, 2015
American Chemical Society Nano
Glioblastoma multiform (GBM) is one of the most malignant forms of brain tumors with very few treatment options other than aggressive surgical removal and radiotherapy. While most conventional chemotherapeutics fail when it comes to GBM, it is anti...
Application Note
Mar 15, 2022
Video
Aug 16, 2017
2nd Annual Nanomedicines Symposium, July 15th, 2017 Cambridge MA
Video
Jul 26, 2016
Targeted mRNA delivery to the Liver for Intracellular Enzyme Replacement Therapy | Pierrot Harvie, PhaseRX
Video
Nov 30, 2016
Nanomedicines Symposium, November 29th, 2016 - LONDON UK
Dominik Witzigmann - Targeted DNA Therapeutics- Hepatic Diseases - University of Basel
Video
Nov 30, 2016
Nanomedicines Symposium, November 29th, 2016 - LONDON UK
Stephen Hart - Targeted Lipid/Peptide Nanocomplexes for Nucleic Acid Delivery - UCL
Video
Sep 10, 2017
2nd Annual Nanomedicines Symposium, July 15th, 2017
To Target or Not to Target: Lessons from RNAi-Based Targeted Lipid Nanoparticles - Dan Peer, Tel-Aviv University
Webinar
Mar 16, 2017
Dr. Dominik Witzigmann, University of Basel
Article
Jun 05, 2023
